Literature DB >> 34401785

An optimized protocol for the retroviral transduction of mouse CD4 T cells.

Ekaterina Eremenko1,2,3,4, Zoe V Taylor1,2,4, Bishnu Khand1,2,4, Shir Zaccai1,2,3,4, Angel Porgador1,2,4, Alon Monsonego1,2,4.   

Abstract

Transduction of primary T cells has become prominent with the introduction of chimeric antigen receptor T-cell therapy. Although there are many protocols for the transduction of human T cells, it remains a challenge to transduce murine T cells. We present an optimized protocol for the retroviral transduction of murine CD4 T cells, which overcomes major challenges including large-scale production and long-term culturing of transduced cells. The optimized protocol combines high transduction efficiency with a low rate of cell death. For complete details on the use and execution of this protocol, please refer to Eremenko et al., 2019.
© 2021 The Author(s).

Entities:  

Keywords:  Cell culture; Cell separation/fractionation; Cell-based Assays; Immunology; Molecular Biology

Mesh:

Year:  2021        PMID: 34401785      PMCID: PMC8353356          DOI: 10.1016/j.xpro.2021.100719

Source DB:  PubMed          Journal:  STAR Protoc        ISSN: 2666-1667


Before you begin

This protocol describes an efficient method for the transduction of CD4 murine T cells, based on retroviral (RV) delivery of genes of interest. It presents as a useful resource for the generation of mouse CAR-T cells, enabling researchers to drive this area of research forward. The common protocol includes several steps such as, viral packaging, isolation and preparation of CD4 T cells for viral transduction and expansion of the transduced cells in culture. This optimized protocol enables the large-scale production of RV-transduced T cells, previously presented as a major challenge, owing to the limited proliferation capability and poor cell survival. Our protocol utilizes the packaging cell line, Platinum-E (Plat-E) cells, to produce retroviral particles, which can stably produce retroviruses with an average titer of 1 × 107 cfu/mL (Morita et al., 2000). Although it is widely accepted that IL-2 is necessary for T cell cultures (Zhang et al., 2020), recent studies indicate the benefit of adding other cytokines, such as IL-7 and IL-15 (Xu et al., 2014; Alvarez-Fernández et al., 2016; Hurton et al., 2016; Alizadeh et al., 2019). IL-7, was found to maintain the survival of human T cells in vitro (Rathmell et al., 2001). We found that the combination of IL-2 and IL-7 increased the long-term survival of mouse CD4-transduced T cells. When working with RV supernatants and RV-transduced samples it is important to follow the universal precautions. All experiments should be carried out in at least a class II biological safety cabinet with appropriate protective equipment, including a lab coat, protective sleeves, and double gloves. Detergents or ethanol can readily inactivate retroviruses owing to the retrovirus being surrounded by a lipid membrane derived from the virus-producing cell (Coffin et al., 1997).

Culturing plat-E cells

Timing: 2 weeks Thaw Plat-E cells, routinely stored at −80°C. Suspend in 15 mL 293T medium and incubate in a 75 cm2 flask at 37°C in a humidified 5% CO2-containing incubator. Once the cells reach a confluence of around 85%–90%, detach cells by adding 2 mL trypsin-EDTA 0.05% and incubate at 37°C in a humidified 5% CO2-containing incubator for 3 min. Collect the cells into a 15 mL conical tube followed by washing the flask with 8 mL 293T medium. Centrifuge at 500 × g for 5 min at 22°C. Remove the supernatant and resuspend the cells in Plat-E medium. Divide the cells to two new 75 cm2 flasks and make up to 15 mL with Plat-E medium. Incubate at 37°C in a humidified 5% CO2-containing incubator. Treat cells biweekly, as described above.

Mice

Ideally use male or female, 8–12 weeks old C57BL/6 mice. Note: Mice are housed under standard conditions, in a 12-h light/dark cycle with food and water supplied ad libitum. All procedures are performed under the approval of the Ben-Gurion University of the Negev Animal Care and Use Committee. All efforts are made to minimize suffering of the animals.

Plasmid generation

Timing: 2 h Prepare plasmid stocks using standard molecular biology techniques following the manufacturer instructions of the PurelinkTM HiPure Plasmid Filter Maxiprep Kit (Invitrogen) or an alternative preferred kit. Determine the DNA concentration of the plasmid using NanoDrop spectrophotometer. Ensure there is sufficient plasmid concentration for the experiment.

Key resources table

In theory, all reagents and resources listed in the ‘key resources table’ can be substituted with equivalent items from other suppliers, with exception to the critical commercial assays and NuncTM Non-Treated Multi-dishes 24 wells; however, it should be noted that the protocol has been calibrated to the reagents listed in the above table and alternatives have not been tested on the protocol performance.

Materials and equipment

293T Medium Store at 4°C for up to one month. Plat-E Medium Store at 4°C for up to one month. Complete RPMI Medium Store at 4°C for up to one month. EasySepTM Mouse CD4 T-cell Isolation Kit Recommended Medium Aliquot and store at - 20°C for up to one year. DynabeadsTM Mouse T-Activator CD3/CD28 for T-Cell Expansion and Activation Buffer Aliquot and store at - 20°C for up to one year. Cell Sorting Medium Store at 4°C for up to one month.

Step-by-step method details

Retroviral virus production

Timing: 4 days Plat-E cells were transfected with a DNA plasmid to produce the retroviral particles Day 1: Plat - E seeding Before starting, ensure you have enough plasmid for transfection, step 8. Coat 10 cm plates by adding 5 mL of 50 μg/mL poly-D-lysine in sterile water. Incubate at 22°C for 45 min. Wash twice with sterile water to ensure no residues remain. Detach Plat-E cells, previously cultured in Plat-E medium in a 75 cm2 flask. First, aspirate the culture medium and carefully add 2 mL pre-warmed trypsin-EDTA 0.05%. Incubate at 37°C in a humidified 5% CO2-containing incubator until the cells are detached, 3–5 min. Wash flask out with 8 mL medium and collect the supernatant in a 15 mL conical tube. Wash cells twice by centrifuging at 500 × g for 5 min and replacing the supernatant with fresh medium. Count the cells using a hemocytometer. Seed Plat-E cells in the coated plates, 3 × 106 cells per plate. Incubate for 16 h at 37°C in a humidified 5% CO2-containing incubator. Day 2: Transfection of Plat-E cells Once Plat-E cells are 85%–90% confluent, replace the medium with 10 mL DMEM medium supplemented with 10% (v/v) FBS and 1 mg/mL streptomycin, 100 U/mL penicillin. Prepare the materials for transfection by adding the required volume of DMEM, without supplements, to each 1.5 mL Eppendorf tube. In one tube add 15 μg of the DNA plasmid [in this case pMP71Gpre GFP (Engels et al., 2003)] and in the other tube add 45 μL Lipofectamine. The final volume in each Eppendorf tube should be 250 μL. The concentration of the plasmid is checked prior to transfection. Transfer the diluted Lipofectamine to the diluted DNA solution and immediately pipette up and down 3–4 times. Incubate at 22°C for 20 min to allow Lipofectamine/DNA complexes to form. After 20 min, mix well and add (dropwise) to the Plat-E plates. Gently swirl the plate and incubate for 16 h at 37°C in a humidified 5% CO2 containing incubator. Replace the medium with DMEM medium supplemented with 10% (v/v) FBS and 1 mg/mL streptomycin, 100 U/mL penicillin.

Isolation and activation of CD4 T cells

Timing: 1 day CD4 T cells were isolated from C57BL/6 mice spleens and subsequently activated with Dynabeads™ Mouse T-Activator CD3/CD28 Day 3: Isolation of CD4 T cells from mouse spleens and activation with Dynabeads™ Mouse T-Activator CD3/CD28 Check the fluorescence of the transfected Plat-E cells to determine transfection efficiency. The day after transfection, sacrifice male or female C57BL/6 mice, aged 8–12 weeks, with an overdose of isoflurane and harvest the spleens. Collect the spleens to a 10 cm petri-dish filled with 5 mL HBSS. In a BSC2 hood, wash the spleens in 5 mL HBSS in a 10 cm plate. Transfer the washed spleens to a 70 μm cell strainer, placed within a 10 cm plate, with 4 mL HBSS, and using the ridged side of a 3 mL syringe plunger mash the spleens through the cell strainer (Figure 1). Rinse with 10 mL HBSS and transfer the cell suspension to a 15 mL conical tube.
Figure 1

Schematic overview of the retroviral transduction protocol

Step 1: CD4 T cells are isolated from spleens of C57BL/6 mice; Step 2: The retroviral particles are produced using the Plat-E packaging cell line; and Step 3: The CD4 T cells are transduced with the retrovirus.

Schematic overview of the retroviral transduction protocol Step 1: CD4 T cells are isolated from spleens of C57BL/6 mice; Step 2: The retroviral particles are produced using the Plat-E packaging cell line; and Step 3: The CD4 T cells are transduced with the retrovirus. You will get approximately 80 × 106 leukocytes per spleen. Centrifuge at 500 × g for 5 min at 4°C. Remove the HBSS and add 300 μL ACK lysing buffer per spleen. Gently mix with the pellet and incubate for 1 min at 22°C. Next, add 10 mL HBSS and centrifuge at 500 × g for 5 min at 4°C. If the pellet remains red after centrifugation, remove the HBSS and add 150 μL ACK lysing buffer per spleen and incubate at 22°C for 45 s. Next, add 10 mL HBSS and centrifuge at 500 × g for 5 min at 4°C. Remove the HBSS and wash twice by adding 10 mL HBSS and centrifuge at 500 × g for 5 min at 4°C. Isolate CD4 T cells using the EasySep™ Mouse CD4 T Cell Isolation Kit as per manufacturer's instructions. You will get approximately 10% CD4 T cells from the total splenocytes. Count the cells using a hemocytometer and bring to a concentration of 1 × 106 cells per mL in complete RMPI medium. Activate the cells with Dynabeads™ Mouse T-Activator CD3/CD28. First, wash the Dynabeads™ in preparation for use, as follows; Transfer the required volume of Dynabeads™ to a 1.5 mL Eppendorf tube and add an equal volume of washing buffer [PBS supplemented with 0.1% (w/v) BSA and 2 mM EDTA, pH 7.4], or at least 1 mL, and pipette five times. Place the Eppendorf on the DynaMag™ Magnet for 1 min and remove the supernatant. Remove the Eppendorf from the DynaMag™ Magnet and suspend the Dynabeads™ in the same volume of culture medium as the initial volume of Dynabeads™ taken. Add 25 μL of Dynabeads™ per 1 × 106 CD4 T cells. Seed 1 × 106 cells per well in a 24 well plate and incubate at 37°C in a humidified 5% CO2-containing incubator for 16–18 h.

Retroviral transduction of CD4 T cells

Timing: 8 h CD4 T cells were retrovirally transduced with the viral supernatant Day 4: Transduction of CD4 T cells Coat non-treated 24-well plates with 350 μL per well of PBS containing 20 μg/mL RetroNectin®. Pause point: The RetroNectin® coated plates can be stored at 4°C for up to 1 week. Incubate plates for 2 h at 37°C in a humidified 5% CO2-containing incubator. During the incubation, harvest the viral supernatant from the transfected Plat-E cells and centrifuge at 800 × g for 10 min. Filtrate through a 0.45 μm filter. Pause point: The viral supernatant can be stored at 4°C for up to 3 days. Replace with 500 μL per well of PBS supplemented with 2% (w/v) BSA. Incubate at 20°C–22°C for 30 min. Wash twice with PBS. Caution: Ensure BSA is properly washed from the plate by first removing all of the BSA from each well and then washing the wells twice with 1 mL of PBS. Finally ensure all liquid is removed from the wells. Remove the PBS from the washed plates and add 1 mL of the viral supernatant per well. Wrap the plates with plastic wrap and centrifuge at 2000 × g for 4 h at 32°C. Two hours prior to the end of centrifugation, add 80 international units (IU)/mL of recombinant IL-2 to the CD4 T cells. After 2 h, collect the cells to 15 mL conical tubes and centrifuge at 500 × g for 5 min. Collect the supernatant and store at 22°C, for not more than 1 h, for use in step 34. Remove the Dynabeads™ using a DynaMag™ Magnet. Suspend the cells in the collected supernatant. Remove the viral supernatant from the plate and add 1 mL of the CD4 T cell suspension per well, i.e., 1 × 106 cells per well. Re-wrap the plate in the plastic wrap and centrifuge at 800 × g for 30 min at 32°C. Remove the plastic wrap and store at 37°C in a humidified 5% CO2-containing incubator.

Culture and expansion of transduced CD4 T cells

Timing: 10–14 days The transduced CD4 T cells were expanded in culture in complete RPMI medium supplemented with 20 IU of IL-2 and 10 ng/mL IL-7. Day 6: Treatment of transduced cells After 48 h, remove 500 μL from each well and add 500 μL complete RPMI medium supplemented with 20 IU of IL-2 and 10 ng/mL IL-7. Day 7: Cell sorting of transduced cells 72 h post transduction, collect the cells and sort for the positive population using the 70 μm nozzle of the FACSAriaTM III Cell Sorter (Figure 2).
Figure 2

Representative flow cytometry plots outlining the sorting of the transduced GFP-positive CD4 T cells

Plots (left to right) show the percentage of lymphocytes, gating on single cells and the mean fluorescent intensity (MFI) of GFP-positive cells

Representative flow cytometry plots outlining the sorting of the transduced GFP-positive CD4 T cells Plots (left to right) show the percentage of lymphocytes, gating on single cells and the mean fluorescent intensity (MFI) of GFP-positive cells Use medium for cell sorting. The timing of cell sorting can vary but should take place more than 5 days post transduction. It is important to check the fluorescence of the cells before cell sorting. Seed sorted cells, 1 × 106 cells per well, in a 24-well plate in complete RPMI medium supplemented with 20 IU of IL-2 and 10 ng/mL IL-7. Day 9: Activation of sorted cells 48 h post cell sorting, activate the cells with Dynabeads™ Mouse T-Activator CD3/CD28 in complete RPMI medium, as described in step 23. Day 11: Treatment of cells 48 h post cell activation, remove 500 μL of the medium and replace with 500 μL of complete RPMI supplemented with 20 IU of IL-2 and 10 ng/mL IL-7. In order to optimize the protocol and enhance the proliferation and survival of the transduced cells, 10 ng/mL IL-7 was added to the standard RPMI medium supplemented with 20 IU of IL-2 (Figure 3).
Figure 3

Proliferation of retroviral-transduced CD4 T cells in the presence of IL2-/IL-7 medium

CD4 GFP T cells were seeded in a 24 well plate (0.5 × 106 cells per well) in RPMI medium supplemented with either 20 IU IL-2 and 10 ng/mL IL-7 or the control 20 IU RPMI. Cells were counted every two days post activation with Dynabeads™. Each condition had four wells per experiment and the experiment was repeated three times. Error bars represent mean ± SEM.

Every 2 days, while cells are proliferating, carefully pipette and split one well to two. Add 500 μL of fresh complete RPMI supplemented with 20 IU of IL-2 and 10 ng/mL IL-7. Once the cells are resting, replace half of the medium with fresh medium every second day. Activate cells with Dynabeads™ every 7–10 days, as required. Proliferation of retroviral-transduced CD4 T cells in the presence of IL2-/IL-7 medium CD4 GFP T cells were seeded in a 24 well plate (0.5 × 106 cells per well) in RPMI medium supplemented with either 20 IU IL-2 and 10 ng/mL IL-7 or the control 20 IU RPMI. Cells were counted every two days post activation with Dynabeads™. Each condition had four wells per experiment and the experiment was repeated three times. Error bars represent mean ± SEM.

Expected outcomes

Activation of murine CD4 T cells was performed by co-culturing CD3/CD28 Dynabeads™ with the CD4 T cells for 16–18 h prior to transduction. Coating plates for viral integration with RetroNectin® significantly increased the yield of transduced CD4 T cells. We also observed an increased yield of transduced CD4 T cells by incubating the cells with 80 IU of recombinant IL-2 two hours prior to viral transduction. Evaluation of GFP expression by flow cytometry demonstrated an exclusive gene transfer into murine CD4 T cells. Supplementing the transduced murine CD4 T cells with IL-2 and IL-7 increased their viability and proliferation capacity (Figure 3).

Limitations

Since the majority of lentiviruses poorly transduce murine T cells, RV are the favored choice for gene delivery into murine T cells (Kerkar et al., 2011). One of the main restrictions of RV is the transduction of proliferating cells, unlike lentiviruses that can transduce also non-proliferating cells (Cepko and Pear, 2001). Since it is essential to transduce the CD4 T cells during proliferation, we activate the cells with Dynabeads™ Mouse T-Activator CD3/CD28 16–18 h prior to transduction and supplement with 80 IU of recombinant IL-2 for 2 h prior the transduction. It is thus important to validate cell proliferation prior to transduction. The vector size can influence the transduction efficiency, with both retroviral and lentiviral vectors having limited cargo capacity (Simmons and Alberola-Ila, 2016). The limit of the DNA fragment size for retroviral gene transfer is around 11 kb, with DNA fragments larger than 8 kb presenting difficulties to work with (Current protocols in molecular biology; Simmons and Alberola-Ila, 2016). The titer of virus produced is in inversely proportional to construct size (Kumar et al., 2001).

Troubleshooting

Problem 1

Viability of the donor spleens. (step 15)

Potential solution

We recommend using an overdose of isoflurane to sacrifice the donor mice. An alternative euthanasia is CO2 overdose, but this can cause necrosis of the spleen and therefore affect the quantity and viability of the splenocytes.

Problem 2

Low RV transduction efficiency. (steps 2, 8, 14, 25, and 30) Coat tissue culture plates with poly-D-lysine before seeding Plat-E cells to enhance adherence. Otherwise, they are loosely attached and easily dislodged. Check the concentration of the plasmid prior to transfection. Check fluorescence of the Plat-E cells post transfection. Use non–coated plates for spin transduction to increase transduction efficiency. Use RetroNectin to facilitate adsorption of RV to target cells. Keep cells above 22°C to maintain activity. Set centrifuge to 32°C for spin-transduction.

Problem 3

Insufficient activation of CD4 T cells. (steps 24 and 31) Transduce cells 16–18 h post activation with DynabeadsTM. Add IL-2 two hours prior to transduction. IL-2 should be aliquoted and frozen in appropriate volumes as freeze/thaw cycles can reduce the efficacy of IL-2. For activation, seed cells at a density of 1 × 106 cells per well in a 24-well plate.

Problem 4

Viability of the CD4 T cells post transduction. (steps 28 and 36) Carefully wash plates after blocking with BSA by first removing all the BSA and then by washing the well twice with 1 mL of PBS. Finally remove all of the liquid. Do not exceed the recommend centrifugation time of CD4 T cells to viral-coated plates. We recommend 30 min.

Problem 5

Poor viability of the CD4 T cells after cell sorting. (steps 39 and 41) Perform cell sorting in cell sorting medium. Allow sorted cells to rest for at least 48 h before the following activation.

Problem 6

Limited fluorescence of CD4 T cells. Transduce the CD4 T cells twice to increase the transduction efficiency.

Resource availability

Lead contact

Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Ekaterina Eremenko (eremenkoem@gmail.com).

Materials availability

This study did not generate new unique reagents.

Data and code availability

This protocol did not generate/need datasets.
REAGENT or RESOURCESOURCEIDENTIFIER
Chemicals, peptides, and recombinant proteins

Poly-D-lysineSigma-AldrichP6407
PureLinkTM HiPure Plasmid Filter Maxiprep KitInvitrogenK210016
Trypsin-EDTA 0.05 %, phenol redGibco25300054
DMEM MediumGibco11965092
Blasticidin (10 mg/mL) in HEPES BufferInvivoGenAnt-bl-05
Puromycin (10 mg/mL) in H2OSigma-AldrichP9620
Penicillin-Streptomycin Solution (100×)Biological Industries03-031-1B
IsofluranePrimal Critical CareNDC66794-017
pMP71 Gpre GFP plasmidKindly provided by Professor Wolfgang Uckert, Max Delbrück Center for Molecular Medicine, Berlin, GermanyN/A
Lipofectamine™ Transfection ReagentInvitrogen18324012
ACK Lysing BufferGibcoA1049201
Normal Rat SerumSTEMCELL Technologies13551
EDTA 0.5 M, pH 8.0Bio-Lab009012230100
Water, Cell Culture GradeBiological Industries03-055-1A
Human IL-2PeproTech200-02-10UG
Mouse Recombinant IL-7STEMCELL Technologies78054
Fetal Bovine SerumGibco10500-064
RPMI Medium 1640Gibco21875
HEPES Buffer Solution (1M)Biological Industries03-025-1B
MEM Non-Essential Amino Acids Solution (10 mM)Biological Industries01-340-1B
Sodium Pyruvate (100 mM)Biological Industries03-042-1B
β-Mercaptoethanol (14.3 M)Sigma-AldrichM3148
Hank's Balanced Salt Solution (HBSS), no Phenol RedBiological Industries02-016-1A
Dulbecco's Phosphate Buffered Saline (PBS), without Calcium and MagnesiumBiological Industries02-023-1A
Bovine Serum AlbuminMP Biomedicals160069
Cell Trace Blue Cell Proliferation KitInvitrogenC34568
eBioscience Fixable Viability Dye eFlour 780Invitrogen65-0865-14

Experimental models: Cell lines

Plat-E CellsCell BiolabsRV-101

Experimental models: Organisms/strains

C57BL/6Jackson000664

Other

Biological Safety CabinetNuAireNU 425-600E
FACSAriaTM III Cell SorterBD648282
CentrifugeEppendorf5810R
NanoDrop One Microvolume UV-Vis Spectrophotometer with Wi-FiThermo Scientific™ND-ONE-W
Counting ChamberPaul Marienfeld GmbH & Co.KG0610010
15 mL Conical TubesCorning188261
50 mL Conical TubesCorning227270
10 cm Cell Culture Petri Dish NunclonTM Delta SurfaceNuncTM150350
Non-Treated Multidishes 24 wellsNuncTM144530
Cell-Culture Treated Multidishes 24 wellsNuncTM142475
96 Well Round (U) Bottom PlateNuncTM163320
Serological Pipette 10 mL Sterile Individually WrapBar-NaorBNP10S1IPG
Serological Pipette 5 mL Sterile Individually WrapBar-NaorBNP5S1IPG
1.5 mL Eppendorf TubesAxygenMCT-150-C
70 μm Cell StrainerSPL93070
3 mL Disposable Syringe without NeedleMediPlusKL 3ML
DynaMagTM-2 MagnetInvitrogen12321D
EasySepTM MagnetSTEMCELL Technologies18000
CytoFLEX LX Flow CytometerBeckman Coulter
Dissecting ScissorsKent ScientificINS600393-G
ForcepsKent ScientificINS650914-4

293T Medium

ReagentFinal concentrationAmount for 500 mL
Fetal Bovine Serum10% (v/v)50 mL
Penicillin-Streptomycin Solution (100×)1 mg/mL Streptomycin,100 U/mL Penicillin5 mL
DMEM Mediumn/aTo 500 mL

Store at 4°C for up to one month.

Plat-E Medium

ReagentFinal concentrationAmount for 500 mL
Fetal Bovine Serum10% (v/v)50 mL
Penicillin-Streptomycin Solution (100×)1 mg/mL Streptomycin,100 U/mL Penicillin5 mL
Puromycin (10 mg/mL) in H2O1 μg/mL50 μL
Blasticidin (10 mg/mL) in HEPES buffer10 μg/mL500 μL
DMEM Mediumn/aTo 500 mL

Store at 4°C for up to one month.

Complete RPMI Medium

ReagentFinal concentrationAmount for 500 mL
Fetal Bovine Serum10% (v/v)50 mL
Penicillin-Streptomycin Solution (100×)1 mg/mL Streptomycin,100 U/mL Penicillin5 mL
HEPES Buffer Solution (1M)10 mM5 mL
MEM Non-Essential Amino Acids Solution (10 mM)0.1 mM5 mL
Sodium Pyruvate (100 mM)1 mM5 mL
β-mercaptoethanol (14.3 M)50 μM1.75 μL
RPMI Medium 1640n/aTo 500 mL

Store at 4°C for up to one month.

EasySepTM Mouse CD4 T-cell Isolation Kit Recommended Medium

ReagentFinal concentrationAmount for 100 mL
Fetal Bovine Serum2% (v/v)2 mL
EDTA 0.5 M, pH 8.01 mM200 μL
Dulbecco's Phosphate Buffered Saline (PBS), without Calcium and Magnesiumn/aTo 100 mL

Aliquot and store at - 20°C for up to one year.

DynabeadsTM Mouse T-Activator CD3/CD28 for T-Cell Expansion and Activation Buffer

ReagentFinal concentrationAmount for 100 mL
Bovine Serum Albumin0.1% (w/v)0.1 g
EDTA 0.5 M, pH 8.02 mM400 μL
Dulbecco's Phosphate Buffered Saline (PBS), without Calcium and Magnesiumn/aTo 100 mL

Aliquot and store at - 20°C for up to one year.

Cell Sorting Medium

ReagentFinal concentrationAmount for 500 mL
Fetal Bovine Serum20% (v/v)100 mL
Penicillin-Streptomycin Solution (100×)2 mg/mL Streptomycin,200 U/mL Penicillin10 mL
RPMI Medium 1640n/aTo 500 mL

Store at 4°C for up to one month.

  12 in total

1.  Plat-E: an efficient and stable system for transient packaging of retroviruses.

Authors:  S Morita; T Kojima; T Kitamura
Journal:  Gene Ther       Date:  2000-06       Impact factor: 5.250

2.  Systematic determination of the packaging limit of lentiviral vectors.

Authors:  M Kumar; B Keller; N Makalou; R E Sutton
Journal:  Hum Gene Ther       Date:  2001-10-10       Impact factor: 5.695

3.  Retroviral Transduction of T Cells and T Cell Precursors.

Authors:  Amie Simmons; José Alberola-Ila
Journal:  Methods Mol Biol       Date:  2016

4.  Overview of the retrovirus transduction system.

Authors:  C Cepko; W Pear
Journal:  Curr Protoc Mol Biol       Date:  2001-05

5.  Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15.

Authors:  Yang Xu; Ming Zhang; Carlos A Ramos; April Durett; Enli Liu; Olga Dakhova; Hao Liu; Chad J Creighton; Adrian P Gee; Helen E Heslop; Cliona M Rooney; Barbara Savoldo; Gianpietro Dotti
Journal:  Blood       Date:  2014-04-29       Impact factor: 22.113

6.  Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells.

Authors:  Lenka V Hurton; Harjeet Singh; Amer M Najjar; Kirsten C Switzer; Tiejuan Mi; Sourindra Maiti; Simon Olivares; Brian Rabinovich; Helen Huls; Marie-Andrée Forget; Vrushali Datar; Partow Kebriaei; Dean A Lee; Richard E Champlin; Laurence J N Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-14       Impact factor: 11.205

7.  Retroviral vectors for high-level transgene expression in T lymphocytes.

Authors:  Boris Engels; Hakan Cam; Thomas Schüler; Stefano Indraccolo; Monika Gladow; Christopher Baum; Thomas Blankenstein; Wolfgang Uckert
Journal:  Hum Gene Ther       Date:  2003-08-10       Impact factor: 5.695

8.  IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype.

Authors:  Darya Alizadeh; Robyn A Wong; Xin Yang; Dongrui Wang; Joseph R Pecoraro; Cheng-Fu Kuo; Brenda Aguilar; Yue Qi; David K Ann; Renate Starr; Ryan Urak; Xiuli Wang; Stephen J Forman; Christine E Brown
Journal:  Cancer Immunol Res       Date:  2019-03-19       Impact factor: 11.151

9.  A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy.

Authors:  C Alvarez-Fernández; L Escribà-Garcia; S Vidal; J Sierra; J Briones
Journal:  J Transl Med       Date:  2016-07-19       Impact factor: 5.531

10.  BDNF-producing, amyloid β-specific CD4 T cells as targeted drug-delivery vehicles in Alzheimer's disease.

Authors:  Ekaterina Eremenko; Kritika Mittal; Omer Berner; Nikita Kamenetsky; Anna Nemirovsky; Yehezqel Elyahu; Alon Monsonego
Journal:  EBioMedicine       Date:  2019-05-11       Impact factor: 8.143

View more
  1 in total

1.  High-Efficiency Retroviral Transduction for Type 1 Regulatory T Cell Differentiation.

Authors:  Michael C McGee; Avery August; Weishan Huang
Journal:  Bio Protoc       Date:  2022-09-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.